Martin Shkreli is a former pharmaceutical executive convicted of securities fraud, infamous for raising the price of the life-saving drug Daraprim by over 5,000%. His actions sparked global outrage and debates on drug pricing ethics. Investors and regulators study his case to understand market manipulation risks, while patients and advocacy groups benefit by highlighting the need for affordable healthcare reforms.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends